Skip to main content
. 2011 Apr 28;3(2):2223–2242. doi: 10.3390/cancers3022223

Figure 3.

Figure 3.

Serum levels of tumor markers relative to treatment sequence. Arrows indicate timepoints of intratumoral injection of iDC and infusion of AT; R denotes the receipt of IMRT. (A). Elevated levels of NCC-ST-439 declined to normal after treatment in serum samples obtained from a patient with metastatic breast cancer; (B). Elevated serum levels of CEA fell to normal after treatment in a patient with metastatic GI cancer.